Chemcon Speciality Chemicals files Rs 350 crore IPO papers with SEBI

The key customers of the company's pharmaceutical chemicals include Hetero Labs, Laurus Labs, Aurobindo Pharma and IndSwift Laboratories. The shares of the company will be listed on the BSE and the NSE.

New Delhi: Chemcon Speciality Chemicals, a leading manufacturer of pharmaceutical chemicals, has filed draft papers with market regulator Sebi for its proposed initial public offer to raise about Rs 350 crore. The issue comprises a fresh issue of Rs 175 crore and an offer for sale of 43 lakh equity shares from the promoters, according to the draft red herring prospectus (DRHP).

As per market sources, the initial public offer (IPO) size is about Rs 350 crore.

Intensive Fiscal Services and Ambit Capital are the managers of the offer.

The Baroda-based company supplies its products to domestic customers and also export to countries including the US, China, Japan, UAE, Azerbaijan, Serbia, Russia and Malaysia, as per the DRHP.

The key customers of the company's pharmaceutical chemicals include Hetero Labs, Laurus Labs, Aurobindo Pharma and IndSwift Laboratories. The shares of the company will be listed on the BSE and the NSE

Read Also: Ipca Labs to acquire Ramdev Chemical for Rs 108 crore